1887

Abstract

The human antibody response to polyomavirus capsid proteins is not well characterized. Recombinant BK virus (BKV), JC virus (JCV) and simian virus 40 (SV40) virus-like particles (VLP) were produced in a baculovirus system, and mouse monoclonal antibodies (mAbs) to these proteins were generated using standard methods. Nine of 12 BKV mAbs showed neutralizing activity. The non-neutralizing antibodies also bound BKV pseudocapsids in an ELISA binding assay. Most antibodies recognized conformational species-specific epitopes, but several exceptions were found: (i) BKV mAb BK-F11 cross-reacted with a linear buried epitope common to both JCV and SV40 pseudocapsids, (ii) two of six JCV antibodies (JC-6.7 and JC-7.9) and two of 13 SV40 antibodies (VP1-H2 and VP1-I2) recognized linear buried epitopes common to all three viruses and (iii) SV40 antibody VP1-E5 recognized a linear surface epitope on JCV pseudocapsids.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.008391-0
2009-03-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/3/634.html?itemId=/content/journal/jgv/10.1099/vir.0.008391-0&mimeType=html&fmt=ahah

References

  1. Atwood, W. J. ( 2001; ). A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy. J Neurovirol 7, 307–310.[CrossRef]
    [Google Scholar]
  2. Bohl, D. L., Ryschkewitsch, C., Major, E. O., Storch, G. A. & Brennan, D. C. ( 2005; ). BK virus antibody titers markedly increase with viremia. Am J Transplant 5 (Suppl.), 273
    [Google Scholar]
  3. Carter, J. J., Madeleine, M. M., Wipf, G. C., Garcea, R. L., Pipkin, P. A., Minor, P. D. & Galloway, D. A. ( 2003; ). Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 95, 1522–1530.[CrossRef]
    [Google Scholar]
  4. Christensen, N. D., Dillner, J., Eklund, C., Carter, J. J., Wipf, G. C., Reed, C. A., Cladel, N. M. & Galloway, D. A. ( 1996a; ). Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223, 174–184.[CrossRef]
    [Google Scholar]
  5. Christensen, N. D., Reed, C. A., Cladel, N. M., Hall, K. & Leiserowitz, G. S. ( 1996b; ). Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology 224, 477–486.[CrossRef]
    [Google Scholar]
  6. Culp, T. D. & Christensen, N. D. ( 2003; ). Quantitative RT-PCR assay for HPV infection in cultured cells. J Virol Methods 111, 135–144.[CrossRef]
    [Google Scholar]
  7. de Sanjose, S., Shah, K. V., Domingo-Domenech, E., Engels, E. A., Fernandez de Sevilla, A., Alvaro, T., Garcia-Villanueva, M., Romagosa, V., Gonzalez-Barca, E. & Viscidi, R. P. ( 2003; ). Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 104, 522–524.[CrossRef]
    [Google Scholar]
  8. Drachenberg, C. B., Beskow, C. O., Cangro, C. B., Bourquin, P. M., Simsir, A., Fink, J., Weir, M. R., Klassen, D. K., Bartlett, S. T. & Papadimitriou, J. C. ( 1999; ). Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol 30, 970–977.[CrossRef]
    [Google Scholar]
  9. Drachenberg, R. C., Drachenberg, C. B., Papadimitriou, J. C., Ramos, E., Fink, J. C., Wali, R., Weir, M. R., Cangro, C. B., Klassen, D. K. & other authors ( 2001; ). Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 1, 373–381.[CrossRef]
    [Google Scholar]
  10. Drachenberg, C. B., Papadimitriou, J. C., Wali, R., Cubitt, C. L. & Ramos, E. ( 2003; ). BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant 3, 1383–1392.[CrossRef]
    [Google Scholar]
  11. Engels, E. A., Viscidi, R. P., Galloway, D. A., Carter, J. J., Cerhan, J. R., Davis, S., Cozen, W., Severson, R. K., de Sanjose, S. & other authors ( 2004; ). Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 96, 1368–1374.[CrossRef]
    [Google Scholar]
  12. Flaegstad, T., Traavik, T., Christie, K. E. & Joergensen, J. ( 1986; ). Neutralization test for BK virus: plaque reduction detected by immunoperoxidase staining. J Med Virol 19, 287–296.[CrossRef]
    [Google Scholar]
  13. Fleury, M. J., Touze, A., de Sanjose, S., Bosch, F. X., Klaustermeiyer, J. & Coursaget, P. ( 2008; ). Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin Vaccine Immunol 15, 172–175.[CrossRef]
    [Google Scholar]
  14. Hamilton, R. S., Gravell, M. & Major, E. O. ( 2000; ). Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 38, 105–109.
    [Google Scholar]
  15. Hariharan, S., Cohen, E. P., Vasudev, B., Orentas, R., Viscidi, R. P., Kakela, J. & DuChateau, B. ( 2005; ). BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 5, 2719–2724.[CrossRef]
    [Google Scholar]
  16. Hirsch, H. H., Mohaupt, M. & Klimkait, T. ( 2001; ). Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 184, 1494–1495.[CrossRef]
    [Google Scholar]
  17. Jafar, S., Rodriguez-Barradas, M., Graham, D. Y. & Butel, J. S. ( 1998; ). Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 54, 276–284.[CrossRef]
    [Google Scholar]
  18. Knowles, W. A., Pipkin, P., Andrews, N., Vyse, A., Minor, P., Brown, D. W. & Miller, E. ( 2003; ). Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71, 115–123.[CrossRef]
    [Google Scholar]
  19. Krymskaya, L., Sharma, M. C., Martinez, J., Haq, W., Huang, E. C., Limaye, A. P., Diamond, D. J. & Lacey, S. F. ( 2005; ). Cross reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 79, 11170–11178.[CrossRef]
    [Google Scholar]
  20. Mylonakis, E., Goes, N., Rubin, R. H., Cosimi, A. B., Colvin, R. B. & Fishman, J. A. ( 2001; ). BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 72, 1587–1592.[CrossRef]
    [Google Scholar]
  21. Nickeleit, V., Hirsch, H. H., Binet, I. F., Gudat, F., Prince, O., Dalquen, P., Thiel, G. & Mihatsch, M. J. ( 1999; ). Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 10, 1080–1089.
    [Google Scholar]
  22. Ramos, E., Drachenberg, C. B., Papadimitriou, J. C., Hamze, O., Fink, J. C., Klassen, D. K., Drachenberg, R. C., Wiland, A., Wali, R. & other authors ( 2002; ). Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13, 2145–2151.[CrossRef]
    [Google Scholar]
  23. Randhawa, P. S. & Demetris, A. J. ( 2000; ). Nephropathy due to polyomavirus type BK. N Engl J Med 342, 1361–1363.[CrossRef]
    [Google Scholar]
  24. Randhawa, P. S., Finkelstein, S., Scantlebury, V., Shapiro, R., Vivas, C., Jordan, M., Pickin, M. M. & Demetris, A. J. ( 1999; ). Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67, 103–109.[CrossRef]
    [Google Scholar]
  25. Randhawa, P. S., Vats, A., Shapiro, R., Weck, K. & Scantlebury, V. ( 2002a; ). BK virus: discovery, epidemiology, and biology. Graft 5 (Suppl.), S19–S27.[CrossRef]
    [Google Scholar]
  26. Randhawa, P. S., Vats, A., Zygmunt, D., Swalsky, P. A., Scantlebury, V., Shapiro, R. & Finkelstein, S. ( 2002b; ). Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74, 485–488.[CrossRef]
    [Google Scholar]
  27. Randhawa, P. S., Gupta, G., Vats, A., Shapiro, R. & Viscidi, R. P. ( 2006; ). Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 13, 1057–1063.[CrossRef]
    [Google Scholar]
  28. Rizk, R. Z., Christensen, N. D., Michael, K. M., Müller, M., Sehr, P., Waterboer, T. & Pawlita, M. ( 2008; ). Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol 89, 117–129.[CrossRef]
    [Google Scholar]
  29. Rosen, S., Harmon, W., Krensky, A. M., Edelson, P. J., Padgett, B. L., Grinnell, B. W., Rubino, M. J. & Walker, D. L. ( 1983; ). Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 308, 1192–1196.[CrossRef]
    [Google Scholar]
  30. Shah, K. V., Ozer, H. L., Ghazey, H. N. & Kelly, T. J. ( 1977; ). Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup. J Virol 21, 179–186.
    [Google Scholar]
  31. Tevethia, S. S. & Schell, T. D. ( 2001; ). The immune response to SV40, JCV, and BKV. In Human polyomaviruses: molecular and clinical perspectives, pp. 585–610. Edited by K. Khalili & G. L. Stoner. New York: Wiley-Liss.
  32. Thönes, N., Herreiner, A., Schädlich, L., Piuko, K. & Müller, M. ( 2008; ). A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response. J Virol 82, 5472–5485.[CrossRef]
    [Google Scholar]
  33. Vallbracht, A., Löhler, J., Gossmann, J., Glück, T., Petersen, D., Gerth, H. J., Gencic, M. & Dörries, K. ( 1993; ). Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 143, 29–39.
    [Google Scholar]
  34. Viscidi, R. P. & Clayman, B. ( 2006; ). Serological cross reactivity between polyomavirus capsids. In Polyomaviruses and human diseases, pp. 73–84. Edited by N. Ahsan. New York: Springer.
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.008391-0
Loading
/content/journal/jgv/10.1099/vir.0.008391-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error